Výsledky vyhledávání - "Lida Kalmanti"

Bleeding Issues in Women Under Oral Anticoagulation

Autor: Lida Kalmanti, Edelgard Lindhoff-Last

Publikováno v: Hamostaseologie. 42(5)

In premenopausal women treatment with direct oral anticoagulants (DOACs) can be associated with an increased risk of heavy menstrual bleeding (HMB) compared with vitamin K antagonists. These findings come from retrospective or prospective single-cent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b67b300de68f3401b8610cde18d3365
https://pubmed.ncbi.nlm.nih.gov/36323281

Zobrazit plný text záznamu

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Publikováno v: Leukemia
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Kalmanti, Lida; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Haferlach, Claudia; Schlegelberger, Brigitte; Fabarius, Alice; Seifarth, Wolfgang; Spieß, Birgit; Wuchter, Patrick; Krause, Stefan; Kolb, Hans-Jochem; Neubauer, Andreas; Hossfeld, Dieter K; Nerl, Christoph; Gratwohl, Alois; Baerlocher, Gabriela M.; ... (2020). High-risk additional chromosomal abnormalities at low blast counts herald death by CML. Leukemia, 34(8), pp. 2074-2086. Springer Nature 10.1038/s41375-020-0826-9
Leukemia, 34(8), 2074-2086. Nature Publishing Group
for the SAKK and the German CML Study Group 2020, ' High-risk additional chromosomal abnormalities at low blast counts herald death by CML ', Leukemia, vol. 34, no. 8, pp. 2074-2086 . https://doi.org/10.1038/s41375-020-0826-9

Blast crisis is one of the remaining challenges in chronic myeloid leukemia (CML). Whether additional chromosomal abnormalities (ACAs) enable an earlier recognition of imminent blastic proliferation and a timelier change of treatment is unknown. One

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8887d4877356618fbfbadf9f6a453a72
https://pubmed.ncbi.nlm.nih.gov/32913312

Zobrazit plný text záznamu

Treatment of Vascular Thrombosis in Antiphospholipid Syndrome: An Update

Autor: Lida Kalmanti, Edelgard Lindhoff-Last

Publikováno v: Hamostaseologie. 40(1)

The antiphospholipid syndrome (APS) is an acquired autoimmune disorder associated with arterial, venous, or microvascular thrombosis and/or pregnancy complications mainly in young age. The diagnosis is made by the persistent detection of anticardioli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a5cdb79de8b57e91ff7015384cc1ad
https://pubmed.ncbi.nlm.nih.gov/31994163

Zobrazit plný text záznamu

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Autor: S. Frühauf, R. Hansen, H. Munzinger, Urs Hess, X. Schiel, O. Stötzer, Holger Hebart, Mathias Hänel, S. Weidenhöfer, E. Jäger, H. Becker, Susanne Saußele, R. Gaeckler, F. Hartmann, Lorenz Trümper, W. Wuillemin, Thomas Illmer, W. Pommerien, Carlo Aul, P. le Coutre, W. Elsel, Otto Prümmer, A. Wehmeier, O. Klein, F. Schlegel, Sebastien Rinaldetti, D. Kingreen, Martin Bentz, J. Menzel, L. Hahn, R. Pihusch, Michael Schenk, Renate Arnold, Dietrich Kämpfe, B. Oldenkott, Alice Fabarius, M. Hahn, H. Eschenburg, A. Grote-Metke, M. Neise, Y. Dencausse, H. Köster, U. Vehling-Kaiser, M. Wattad, K. Stahlhut, H. Weischer, R. Moeller, Markus Pfirrmann, K. Neben, H. Tessen, A. Raghavachar, Peter Brossart, Hans-Heinrich Wolf, M. Hofknecht, Roland Schroers, Thomas Geer, Matthias Edinger, Axel R. Zander, R. Rudolph, F. Stegelmann, Winfried Gassmann, K. Ranft, A. Matzdorff, Christoph Scheid, M. Sosada, M. Sieber, G. Köchling, W. Fett, T. Herrmann, Rudolf Schlag, C. Maintz, S. Schanz, S. Hentschke, Peter Reichert, Dietrich W. Beelen, Alois Gratwohl, S. Schmitz, Michael Lauseker, Gabriela M. Baerlocher, H. P. Weidelich, F. Müller, B. Sievers, Alexander Kiani, J. Heßling, P. Majunke, W. Hollburg, D. Reschke, S. Wagner, B. Rendenbach, G. Käfer, W. Ludwig, Claudia Haferlach, A. Lochter, G. Baake, A. Schmalenbach, Y. Ko, R. Schwerdtfeger, Cornelius F. Waller, J. Mittermüller, Wolfgang E. Berdel, Walter Verbeek, C. Sperling, T. Fischer Huber, Karsten Spiekermann, C. Spohn, H. Pralle, Ch Scholz, C. Schelenz, H. Schick, A. D. Ho, Robert Dengler, C. Lunscken, D. Assman, H. Hoeffkes, A. Nusch, Hans-Walter Lindemann, B. Göttler, Günter Schlimok, H. Fiechtner, Patrick Wuchter, H. Forstbauer, C. Müller-Naendrup, J. Krauter, M. Planker, W. Langer, L. Schulz, Andreas Hochhaus, Hartmut Link, Philippe Schafhausen, Bernd Hertenstein, Andreas Neubauer, C. Schadeck-Gressel, M. Hoffknecht, L. Balleisen, A. Henzel, E. Ladda, Dieter K. Hossfeld, I. Blau, Jörg Hasford, V. Petersen, Christoph Nerl, M. Flaßhove, C. Lamberti, Stephan Kremers, Wassman, S. Korsten, Hans-Jochem Kolb, G. Adam, Michele Baccarani, M. Demandt, S. Al-Batran, S. Rösel, Jolanta Dengler, T. Neuhaus, Martin Griesshammer, B. Kempf, K. Josten, M. Sauer, W. Gröschel, U. Hieber, V. Runde, A. Urmersbach, Lutz P. Müller, Rüdiger Hehlmann, D. Linck, M. Hemeier, U. Martens, T. Kamp, S. Völkl, C. Diekmann, Andreas Burchert, T. Reiber, S. Bildat, J. Gmür, M. Uppenkamp, M. Simon, T. Zöller, Lothar Kanz, H. Strotkötter, N. Kalhori, R. Janz, Brigitte Schlegelberger, A. Hoyer, Wolfgang Seifarth, S. Stier, Katharina Kohlbrenner, J. Heymanns, J. Schleicher, Stefan W. Krause, M. de Wit, Antonio Pezzutto, D. Behringer, A. Lollert, H. Hitz, J. Janssen, G. Trenn, C. Lange, R. Depenbusch, A. Lindemann, H. Dietzfelbinger, B. Bechtel, B. Koch, B. Uebelmesser, U. Burkhardt, R. Fuchs, M. Schatz, S. Brettner, G. Heil, D. Hossfeld, Norbert Schmitz, C. Scheidegger, D. Reichert, M. Baldus, Michael J. Eckart, Axel A. Fauser, Lida Kalmanti, Birgit Spieß, Jiří Mayer, C. Ploger, C. A. Köhne, C. Priebe-Richter, C. Denzlinger, G. Doering, G. Springer, Tim H. Brümmendorf, Dominik Heim, Michael Kneba, I. M. Pfreundschuh, S. Jacki, M. Stauch, M. Kemmerling, Martin Wernli, A. Bartholomäus, Astghik Voskanyan, B. Sandritter, S. Fetscher, B. Goldmann, M. C. Goebler, C. Falge, Heinz Dürk, L. Fischer von Weikersthal, H. Baurmann, G. Ehninger, E. Schäfer, M. Schröder, F. Möller-Faßbender, K. Tajrobehkar, P. Schmidt, Christian A. Schmidt, A. Waladkhani, W. Freier, F. Henneke

Publikováno v: Leukemia. 34:2823-2823

Korrektur zu 10.1038/s41375-020-0826-9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3838e36271d853db87ddead9d9cb2b6
https://doi.org/10.1038/s41375-020-01039-7

Zobrazit plný text záznamu

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Publikováno v: Leukemia. 29:1123-1132

Tyrosine kinase inhibitors (TKI) have changed the natural course of chronic myeloid leukemia (CML). With the advent of second-generation TKI safety and efficacy issues have gained interest. The randomized CML - Study IV was used for a long-term evalu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446b12b21cdf1ff383ba0f43e5b64940
https://doi.org/10.1038/leu.2015.36

Zobrazit plný text záznamu

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV

Publikováno v: Annals of Hematology
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C; Hanfstein, Benjamin; Krause, Stefan W; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; ... (2014). Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Annals of hematology, 93(7), pp. 1167-1176. Springer 10.1007/s00277-014-2041-0

The impact of imatinib dose on response rates and survival in older patients with chronic myeloid leukemia in chronic phase has not been studied well. We analyzed data from the German CML-Study IV, a randomized five-arm treatment optimization study i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8fd0451ec79f06e5dfe71042cc4735
http://europepmc.org/articles/PMC4050299

Zobrazit plný text záznamu

Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML)

Autor: Christian Dietz, Martin C. Müller, Daniel Nowak, U. Munjal, Maximilian Mossner, Wolfgang Seifarth, Andreas Hochhaus, Juliana Schwaab, Benjamin Hanfstein, W.-K. Hofmann, Lida Kalmanti, M. Philipp, Philipp Erben

Publikováno v: Journal of Cancer Research and Clinical Oncology. 140:411-417

Overexpression of transketolase-like gene 1 (TKTL1) on RNA and protein level has been linked to tumour progression, metastasis and unfavourable patient outcome in many solid tumours. Chronic myeloid leukaemia (CML) cells show metabolic characteristic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f9fcdecf47fdd550265227dc017fdb
https://doi.org/10.1007/s00432-013-1579-x

Zobrazit plný text záznamu

High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels

Publikováno v: Blood. 134:666-666

Background. The end phase or metamorphosis is one of the remaining challenges of chronic myeloid leukemia (CML) management. Blast crisis (BC) is a late marker. Earlier diagnosis may improve outcome. The detection of additional chromosomal abnormaliti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e9656d844fc6b0705a97151ddc7a817d
https://doi.org/10.1182/blood-2019-127127

Zobrazit plný text záznamu

CD133 immunomagnetic separation: effectiveness of the method for CD133+ isolation from umbilical cord blood

Autor: Lida Kalmanti, Helen Dimitriou, Iordanis Pelagiadis, Konstantinos Relakis

Publikováno v: Cytotherapy. 14:701-706

Umbilical cord blood (UCB) is a rich source of stem cells, the characterization and isolation of which requires specific stem cell markers and reliable and reproducible protocols.We assessed CD133 isolation in 39 UCB samples, using a commercial immun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e31581940b3000e18f1e2a3340fafc
https://doi.org/10.3109/14653249.2012.663487

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání